$2.68T
Total marketcap
$45.95B
Total volume
BTC 49.88%     ETH 17.07%
Dominance

Curative Biosciences CBDX Stock

0.0015 USD {{ price }} 0.000000% {{change_pct}}%
Market Cap
9.34M USD
LOW - HIGH [24H]
0.0015 - 0.0015 USD
VOLUME [24H]
10K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Curative Biosciences Price Chart

Curative Biosciences CBDX Financial and Trading Overview

Curative Biosciences stock price 0.0015 USD
Previous Close 0.0014 USD
Open 0.0014 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.0014 - 0.0014 USD
52 Week Range 0.0001 - 0.01 USD
Volume 50 USD
Avg. Volume 173 USD
Market Cap 9.34M USD
Beta (5Y Monthly) 8.09014
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

CBDX Valuation Measures

Enterprise Value 199.68K USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.387

Trading Information

Curative Biosciences Stock Price History

Beta (5Y Monthly) 8.09014
52-Week Change 100.00%
S&P500 52-Week Change 20.43%
52 Week High 0.01 USD
52 Week Low 0.0001 USD
50-Day Moving Average 0.000696 USD
200-Day Moving Average 0.002379 USD

CBDX Share Statistics

Avg. Volume (3 month) 173 USD
Avg. Daily Volume (10-Days) 146 USD
Shares Outstanding 31.57M
Float 7.5M
Short Ratio N/A
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:100

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2017
Most Recent Quarter (mrq) March 31, 2018
Next Fiscal Year End June 30, 2018

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -3843.89%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -515488 USD
Net Income Avi to Common (ttm) -518096 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 982 USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 156.45K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.001
Book Value Per Share (mrq) -0.036

Cash Flow Statement

Operating Cash Flow (ttm) -81808 USD
Levered Free Cash Flow (ttm) N/A

Profile of Curative Biosciences

Country United States
State FL
City Miami
Address 801 Brickell Avenue
ZIP 33131
Phone N/A
Website https://curativebio.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.

Q&A For Curative Biosciences Stock

What is a current CBDX stock price?

Curative Biosciences CBDX stock price today per share is 0.0015 USD.

How to purchase Curative Biosciences stock?

You can buy CBDX shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Curative Biosciences?

The stock symbol or ticker of Curative Biosciences is CBDX.

Which industry does the Curative Biosciences company belong to?

The Curative Biosciences industry is Drug Manufacturers-Specialty & Generic.

How many shares does Curative Biosciences have in circulation?

The max supply of Curative Biosciences shares is 6.23B.

What is Curative Biosciences Price to Earnings Ratio (PE Ratio)?

Curative Biosciences PE Ratio is now.

What was Curative Biosciences earnings per share over the trailing 12 months (TTM)?

Curative Biosciences EPS is 0 USD over the trailing 12 months.

Which sector does the Curative Biosciences company belong to?

The Curative Biosciences sector is Healthcare.